AN

Ananda Pharma Plc

Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BDQPXQ60
LEI:
894500DFM8VOC5FW4X47
Country:
United Kingdom
Address:
6th Floor, 60 Gracechurch Street, EC3V 0HR London
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ananda Pharma Plc is a biopharmaceutical company focused on the development and commercialization of regulatory-approved, cannabinoid-based medicines. The company's pipeline targets complex, chronic conditions with significant unmet medical needs. Key therapeutic areas of focus include inflammatory pain conditions, such as Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, alongside drug-resistant epilepsies and Heart Failure with preserved Ejection Fraction (HFpEF). Ananda's integrated approach spans from initial research and drug candidate optimization through to conducting clinical trials and securing marketing authorizations from regulators to ensure patient access.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Ananda Pharma Plc. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 15:43
Post-Annual General Meeting Information
Result of Annual General Meeting
English 29.6 KB
2025-08-19 08:00
Report Publication Announcement
Webinar Presentation Release
English 21.3 KB
2025-07-30 14:49
Pre-Annual General Meeting Information
Notice of Annual General Meeting
English 21.8 KB
2025-07-30 13:44
Report Publication Announcement
Publication of Annual Report
English 44.2 KB
2025-06-23 08:00
Regulatory News Service
Key Milestone in MRX1 Path to Clinical Trials
English 23.3 KB

Automate Your Workflow. Get a real-time feed of all Ananda Pharma Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ananda Pharma Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
Japan 4886
Astellas Pharma Inc. Logo Japan 4503
AstraZeneca PLC Logo
A global biopharma firm developing medicines for oncology, rare diseases, and biopharmaceuticals.
United Kingdom AZN
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland BANB
Basilea Pharmaceutica AG Logo
Develops and commercializes anti-infective drugs for severe bacterial and fungal infections.
Switzerland BSLN